Ingredients for the treatment and prevention of ulcers, ulcers and / or symptoms, including gastric and intestinal ulcers, such as In non-human animals, especially horses Methods of treating the affected animals, the ingredients of which include reducing or inhibiting the effective amount of one or more acids of the drug, such as antacids and / or inhibitors of proton pumps, and the effective amount of pre cyanide polymers of croton lechleri, Or from Croton lechleriWhether it's gut or non gut Ulcer treatment ingredients are made from pastes, gels, or gel pastes containing related particles, including antacids, proton pump inhibitors, croton lechleri's procyanopyridine polymer, croton lechleri's extract, and other ingredients, In particular, a supply system is provided in the large intestine to treat and prevent ulcers in animals in need. Claim 5: the drug ingredient in claim 4, proton pump inhibitor, was selected from omeprazol (Prilosec, gastogard, ulbergard),rabeprazol (ACIPHEX ACIFIX)esomeprazol (NEXIUM)Or legs (protonix). Claim 10: the composition of the drug under claim 9, in which the target country of H-2 receptor is selected from Tagamet,ranitidina (ZANTAC)nizatidina (AXID AXID AR)or famotidine (PEPCID). Claim 20: The pharmaceutical composition according to claim 19, wherein the Croton lechleri proanthocyanidin polymer composition is SB 300. Claim 23: The composition according to claim 22, wherein the core further comprises one or more of sucralfate, misoprostol, vitamins A, B1, B2, B6, B12, D3, E and K, or deglycyrrhizinated licorice. Claim 32: The composition according to claim 31, wherein the pH sensitive layer or coating comprises an EUDRAGIT® methacrylic acid polymer.Composiciones para tratar y prevenir úlceras, trastornos ulcerativos y/o los síntomas de los mismos, incluyendo úlceras gástricas, intestinales, por ej. duodenales y colónicas en animales no humanos, especialmente caballos. Los métodos que involucran tratar un animal afectado con composicio
